Bacteria and fungi might increase risk of head and neck cancers

Source: www.medicalnewstoday.com Author: staff Head and neck squamous cell carcinoma (HNSCC), which develops in the mucous membranes of the mouth, nose, and throat, is the sixth most common type of cancer worldwide. Globally, there were approximately 890,000 new cases of HNSCC and 450,000 associated deaths in 2018. Risk factorsTrusted Source for HNSCC include tobacco use, alcohol consumption, and human papillomavirus (HPV) infection. Researchers at São Paulo State University (UNESP) in Araraquara, Brazil, hope that learning more about metabolomicsTrusted Source — the analysis of metabolites in an organism — will prove key to developing a better understanding of these types of cancer. The researchers conducted a laboratory study that showed how fungi and bacteria can activate genes associated with head and neck tumors. The study appears in Frontiers in Cellular and Infection Microbiology. The researchers’ work suggests that the metabolism of biofilms stimulates tumor cells by favoring cell signaling pathways that are required for tumor development. Biofilms occur when bacteria congregate and form a community. Specifically, the study details how biofilms secrete metabolites, which are the intermediate or end product of metabolism. These metabolites can modify the expression of genes that experts associate with tumor cell growth. “It was very exciting for us that we found a relationship between the metabolites of these microbes [and cell behavior],” Dr. Paula Aboud Barbugli, a professor at UNESP’s Araraquara Dental School and co-leader of the study, told Medical News Today. Microorganisms and cancer cells The researchers introduced metabolites from biofilms to healthy oral epithelial [...]

Study finds major anti-inflammatory immune activity that favors oral cancer tumors

Source: medicalxpress.com Author: Melisa Institute A collaborative research led by immunologist Estefania Nova-Lamperti from the Universidad de Concepción (Chile), with a branch of researchers from MELISA Institute and other international academic centers, made progress in the understanding of molecular mechanisms preventing an effective antitumor immune response in oral cancer; The latter due to the production of chemical mediators that induce an anti-inflammatory regulatory response that favors tumor development through the vitamin D signaling pathway. The study was published in Frontiers in Immunology on May 7, 2021. Oral cancer, 90% of which corresponds to the squamous cell type, is a neoplasm with a high mortality and morbidity rate, mainly because the diagnosis is made in late stages when metastases already exist, and where treatment produces serious physical and functional sequel among survivors. It is well known that the immune system plays a key role in the development of cancer, either by stimulating pathways that play an anti-tumor role or, conversely, by generating an anti-inflammatory environment that allows the tumor to grow and be spread. The main biological agents of the immune system are lymphocytes or T cells, which have different functions or phenotypes. In cancer, the presence of regulatory T cells (Tregs) and helper T cells type 2 (Th2) are associated with a worse prognosis, whereas the responses of helper T cells type 1 (Th1) within tumors, in general, show a better prognosis. Dr. Nova-Lamperti points out that a key question in oral cancer is how an anti-inflammatory microenvironment is induced, [...]

Go to Top